Thu, March 28, 2024
Wed, March 27, 2024
Tue, March 26, 2024

Eliana Merle Maintained (BNTX) at Hold with Decreased Target to $101 on, Mar 27th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-101-on-mar-27th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Eliana Merle of UBS, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $110 to $101 on, Mar 27th, 2024.

Eliana has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 1 agrees with Eliana's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $100 on, Wednesday, February 28th, 2024


These are the ratings of the 4 analyists that currently disagree with Eliana


  • Jessica Fye of "JP Morgan" Maintained at Sell with Decreased Target to $90 on, Friday, March 22nd, 2024
  • Bill Maughan of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $171 on, Thursday, March 21st, 2024
  • Etzer Darout of "BMO Capital" Maintained at Buy with Decreased Target to $123 on, Thursday, March 21st, 2024
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $107 on, Tuesday, January 23rd, 2024

Publication Contributing Sources